Docetaxel in Node Positive Adjuvant Breast Cancer

NCT00688740 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1491

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: 5-fluorouracil
DRUG: Doxorubicin
DRUG: Cyclophosphamide

Sponsor

Sanofi

Collaborators

[object Object]